Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

asx:ton

POPULAR ARTICLES

Triton Agrees to Divest 70% of Mozambique Graphite Assets for A$17 million cash

Graphite Investing

Triton Agrees to Divest 70% of Mozambique Graphite Assets for A$17 million cash

Triton Minerals Signs MOU with Suzhou for Ancuabe Services

Graphite Investing

Triton Minerals Signs MOU with Suzhou for Ancuabe Services

Vanadium Investing

Triton to Fast Track Vanadium Study at Nicanda Hill

LATEST ARTICLES

ASX:TON

Graphite Investing

Triton Minerals Signs Second Graphite Offtake Deal for Ancuabe

ASX:TON

Graphite Investing

Triton Minerals Signs First Binding Offtake Deal for Ancuabe Graphite

Triton Delivers Robust Ancuabe Definitive Feasibility Study and Declares Maiden Ore Reserve

ASX:KNL

Graphite Investing

Graphite Companies Respond to Tanzania's New Mining Laws

Graphite Investing

4 Top Graphite Stocks Up in 2016

Triton Confirms Wide Zones of Graphite Mineralization at Balama North

Alternate Graphene Companies to Invest In

Graphene Investing

Alternate Graphene Companies to Invest In

Triton Reports Initial Drill Results from Anucabe Graphite Project

Triton Updates on Metallurgical Results from P66 Zone

Triton Intersects Large Zone of Graphitic Mineralization at Ancuabe

Shenzhen Extends Due Diligence Period on Triton’s Nicanda Hill Project

Triton Minerals Pleased with Ancuabe Flotation Results

Latest News

Gold Rally Sparks Renewed Investor Rush Into Mining Stocks

SAGA Metals Completes Maiden Drill Program and Commences Further Geophysics at the Radar Project

Gold Rally Sparks Renewed Investor Rush Into Mining Stocks

RUA GOLD Expands High-Grade Intercepts at Depth at Auld Creek: 5.9g/t AuEq over 9m and 48.3g/t AuEq over 1.25m

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis